StockNews.com Initiates Coverage on Mannatech (NASDAQ:MTEX)

StockNews.com began coverage on shares of Mannatech (NASDAQ:MTEX) in a report issued on Wednesday. The brokerage set a “buy” rating on the stock.

Mannatech Stock Down 6.1 %

Mannatech stock opened at $8.56 on Wednesday. The stock’s 50 day moving average price is $7.93 and its 200 day moving average price is $7.59. Mannatech has a 1-year low of $6.75 and a 1-year high of $10.51. The company has a market cap of $16.09 million, a PE ratio of -10.57 and a beta of 1.18. The company has a debt-to-equity ratio of 0.44, a current ratio of 1.25 and a quick ratio of 0.74.

Mannatech (NASDAQ:MTEX) last released its earnings results on Tuesday, November 12th. The company reported ($0.17) EPS for the quarter. Mannatech had a negative net margin of 1.26% and a negative return on equity of 15.62%. The business had revenue of $31.73 million during the quarter.

Insider Buying and Selling

In other news, Director Larry A. Jobe sold 16,288 shares of the firm’s stock in a transaction on Monday, September 9th. The stock was sold at an average price of $7.75, for a total value of $126,232.00. Following the completion of the transaction, the director now owns 54,721 shares in the company, valued at $424,087.75. This trade represents a 22.94 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. 41.50% of the stock is currently owned by insiders.

Mannatech Company Profile

Mannatech, Incorporated operates as a health and wellness company in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management and fitness products. It primarily sells its products directly, as well as through e-commerce and network marketing channels.